Next Article in Journal
Comparative Analyses of the Gut Microbiota in Growing Ragdoll Cats and Felinae Cats
Previous Article in Journal
Paraclinical Changes Occurring in Dairy Cows with Spontaneous Subacute Ruminal Acidosis under Field Conditions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Chitosan Oligosaccharide on Production Performance, Egg Quality and Ovarian Function in Laying Hens with Fatty Liver Syndrome

1
Hubei Key Laboratory of Animal Embryo and Molecular Breeding, Institute of Animal Husbandry and Veterinary, Hubei Academy of Agricultural Sciences, Wuhan 430064, China
2
Key Laboratory of Molecular Animal Nutrition, College of Animal Science, Zhejiang University, Ministry of Education, Hangzhou 310058, China
*
Author to whom correspondence should be addressed.
Animals 2022, 12(18), 2465; https://doi.org/10.3390/ani12182465
Submission received: 26 August 2022 / Revised: 13 September 2022 / Accepted: 15 September 2022 / Published: 18 September 2022
(This article belongs to the Section Poultry)

Abstract

:

Simple Summary

Fatty liver syndrome (FLS) often occurs in caged laying hens and can cause decreases in production performance. Chitosan oligosaccharide (COS), degraded from chitin or chitosan, has been demonstrated to prevent metabolic diseases in rodents. In this work, we found that dietary COS supplementation could improve production performance and egg quality in laying hens with FLS. Further study indicated that improved ovarian morphology and function may be involved in these beneficial effects of COS. Specifically, dietary COS supplementation decreased oxidative stress, inflammation and apoptosis in the ovaries of laying hens with FLS. This study provides evidence for the application of COS to improve production performance and egg quality in laying hens with FLS.

Abstract

This study aimed to investigate the role of chitosan oligosaccharide (COS) as an additive in the feed of laying hens with fatty liver syndrome (FLS). Effects on production performance, egg quality as well as ovarian function were determined. A total of 360 Lohmann Pink-shell laying hens (28 weeks old) were randomly assigned to 5 groups (6 replicates × 12 birds). Hens were fed with a basal diet and a high-energy low-protein (HELP) diet supplemented with 0, 200, 400 and 800 mg/kg COS. COS reversed the lowered laying rates, increased feed-to-egg ratios and decreased albumen heights and Haugh units induced by the HELP diet. Additionally, COS improved the ovarian morphologies damaged by the HELP diet. Furthermore, COS enhanced antioxidant enzyme activities, reduced malonaldehyde levels and downregulated the mRNA expressions of nuclear factor kappa B, pro-inflammation cytokine genes and pro-apoptosis-related genes, while it upregulated the mRNA expression of anti-apoptosis-related genes in the ovaries of HELP-diet-fed hens. These findings suggested that dietary COS supplementation could improve production performance and egg quality in laying hens with FLS, and these beneficial effects were linked to improved ovarian morphology, which was attributed to decreased oxidative stress, inflammation and apoptosis in the ovaries.

1. Introduction

Fatty liver syndrome (FLS), characterized by excess lipid accumulation and various degrees of hemorrhage in the liver, often occurs in caged laying hens [1]. FLS can cause a sharp drop in the rate of egg production and can even induce the occurrence of sudden death, resulting in serious economic losses to the poultry industry [2]. There are multiple factors, including heredity, nutrition, hormones and environment, involved in the development of FLS, and nutrition is the leading cause of FLS [3]. In order to elucidate the pathogenesis of FLS and develop effective prevention and treatment strategies, a high-energy low-protein (HELP) diet is widely used to induce FLS in laying hens [4]. Previous studies have demonstrated that HELP diets may induce significant decreased egg production in laying hens [4,5]. The ovary is the key organ affecting reproductive capacity in females; thus, improving ovarian function is beneficial for the production performance of laying hens. It was reported that hepatic fat accumulation is closely associated with abnormal morphology and increased apoptosis in the ovaries of broiler breeder hens [6]. Moreover, a previous study showed that oxidative stress and inflammation in the ovaries are involved in the occurrence and development of FLS in laying hens [7]. These findings suggest that ovarian dysfunction may be the main contributing factor with respect to decreased egg production in laying hens with FLS.
Chitosan oligosaccharide (COS), degraded from chitin or chitosan, possesses various biological properties, such as antioxidant, anti-inflammatory, anti-obesity, hypolipidemic and hypoglycemic activities [8,9]. COS has been used to prevent metabolic diseases, including obesity, dyslipidemia, diabetes mellitus and hypertension [10,11,12,13]. COS could also prevent fatty liver disease in high-fat-diet-fed mice and rats, and these effects were linked to its antioxidant and anti-inflammatory activities [11,14,15]. In addition, COS has potential applications as a feed additive to promote the reproductive performance of livestock and poultry [16,17,18,19]. The beneficial effects of COS on reproductive performance were linked to improved ovarian function in sows [20]. When used as an alternative to antibiotics for laying hens, COS could improve production performance and egg quality under normal physiology conditions [18,19]. Moreover, COS could attenuate intestinal oxidative stress and inflammation in laying hens [21]. COS could also alleviate oxidative stress and inflammation in the livers, spleens and intestines of broilers [22,23]. However, until now, no study has demonstrated the effect of COS on production performance and egg quality in laying hens with FLS. Whether COS could suppress ovarian oxidative stress, inflammation and apoptosis in laying hens with FLS has not been clarified. Therefore, the purpose of the present study was to evaluate the effects of dietary COS supplementation on production performance, egg quality and ovarian function in laying hens with FLS.

2. Materials and Methods

2.1. Animals, Diets and Experimental Design

The experimental protocol was approved by the Animal Care and Use Committee of Hubei Academy of Agricultural Sciences (HBAAS20210007).
A total of 360 Lohmann Pink-shell laying hens (28 weeks old) were randomly assigned to 5 dietary treatments as follows: normal control (NC) group, HELP group, HELP + low dosage of COS (HELPLC) group, HELP + medium dosage of COS (HELPMC) group, HELP + high dosage of COS (HELPHC) group. Each treatment had 6 replicates with 12 hens per replicate. Birds in the NC group were fed a basal diet, and birds in the HELP, HELPLC, HELPMC and HELPHC groups received a HELP diet supplemented with 0, 200, 400, and 800 mg/kg COS, respectively. The basal diet was formulated according to the requirement of laying hens [24], and the HELP diet composition was based on our preliminary experimental results. The compositions and nutrient levels of the basal and HELP diets are shown in Table 1. The COS was obtained from Zhongkerongxin Biotechnology Co., Ltd. (Suzhou, China), with a purity of approximately 90%. The doses of COS were selected based on a previous study [19]. The hens were housed in 3-tier ladder-type cages (6 birds per cage, 80 × 80 × 50 cm) in an environmentally controlled room with a 16L:8D photoperiod. The diets and water were provided ad libitum. The experiment lasted for 14 weeks, including a 2-week adaptation period and a 12-week experimental period.

2.2. Production Performance and Sample Collection

The number and weight of qualified eggs were recorded daily for each replicate. Feed consumption was recorded weekly, and mortality was recorded daily throughout the experiment. The laying rate, daily feed intake and feed-to-egg ratio were calculated for each trial phase and for the overall experimental period. At the end of the trial, one hen from each replicate was randomly selected and sacrificed by jugular exsanguination. The ovary samples were collected for further determination.

2.3. Egg Quality

At the end of the trial, egg samples (8 eggs per replicate, 48 eggs per treatment) were obtained to analyze egg quality. All eggs were weighed using an electronic scale. The longitudinal and transverse diameters of the eggs, as well as the eggshell thicknesses, were measured using a vernier caliper. The egg shape index was calculated as egg longitudinal diameter divided by egg transverse diameter, and eggshell thickness was calculated by averaging three thickness values form the blunt end, middle and sharp end of the shell. Eggshell strength was determined with an eggshell strength meter (NFN388, Fujihira Industry Co. Ltd., Tokyo, Japan). Yolk color was evaluated by comparison with a color fan (Robotmation Co., Ltd., Tokyo, Japan), and the yolk weight ratio was calculated as yolk weight divided by egg weight. Albumen heights and Haugh units were measured using an Egg Multi Tester (EMT-7300, Robotmation, Japan).

2.4. Histopathological Examination

The ovary samples were washed with normal saline and then fixed in 4% paraformaldehyde solution. After fixing for 24 h, the tissues were embedded in paraffin. Then, the tissues were cut into slices of 5 µm thickness and stained with hematoxylin and eosin (H&E). The samples were observed and photographed using a light microscope.

2.5. Determination of Ovarian Antioxidant Capacity

The ovary samples were homogenized in ice-cold 0.9% saline at a ratio of 1:9 (wt/vol). Then, the supernatants were transferred into new Eppendorf tubes after centrifugation at 3000 rpm for 10 min. The activities of total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) and the levels of malondialdehyde (MDA) in the supernatants of the ovaries were assessed using commercial kits from the Nanjing Jiancheng Bioengineering Institute (Nanjing, China), according to the manufacturer’s instructions.

2.6. Quantitative Real-Time Polymerase Chain Reaction (PCR) Analysis

Total RNA was extracted from the ovary samples using TRIzol Reagent (TaKaRa, Dalian, China), and cDNAs were synthesized from 500 ng of RNA using a reverse transcription kit (TaKaRa, Dalian, China), according to the manufacturer’s instructions. Quantitative real-time PCR was performed on a LightCycler 96 PCR System (Roche, Mannheim, Germany) with TB Green Premix Ex Taq II (TaKaRa, Dalian, China). The sequences of primers used for PCR amplification are listed in Table 2. The mRNA expression levels of the target genes were normalized to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and calculated using the 2−ΔΔCT method.

2.7. Statistical Analysis

All data were analyzed by one-way ANOVA followed by Duncan’s test for multiple comparisons using SPSS 20.0 software (SPSS, Chicago, IL, USA). Differences among means were considered significant at levels of p < 0.05.

3. Results

3.1. Production Performance

The effects of dietary COS supplementation on the production performance of the laying hens are presented in Table 3. There were no significant differences in daily feed intake among all the groups during the trial (p > 0.05). From the 1st to the 4th week, the laying rates of hens in the HELP group were lower than those of hens in the NC group, whereas dietary supplementation with COS (400 or 800 mg/kg) obviously increased the laying rates (p < 0.05). Additionally, from the 1st to the 4th week, no difference was observed in feed-to-egg ratios among all the groups (p > 0.05). From the 5th to the 8th week, the hens in the HELP group showed significantly lower laying rates and higher feed-to-egg ratios than those in the NC group (p < 0.05), whereas dietary supplementation with COS (200, 400 or 800 mg/kg) obviously increased the laying rates and decreased the feed-to-egg ratios (p < 0.05). From the 9th to 12th week, the hens in the HELP group showed significantly lower laying rates and higher feed-to-egg ratios than those in the NC group (p < 0.05), whereas, compared with hens in the HELP group, laying rates increased and the feed-to-egg ratios decreased in hens in the HELPMC and HELPHC groups (p < 0.05). From the 1st to the 12th week, the hens in the HELP group showed significantly lower laying rates and higher feed-to-egg ratios than those in the NC group (p < 0.05), whereas, compared with hens in the HELP group, laying rates were increased in hens in the HELPLC, HELPMC and HELPHC groups (p < 0.05), and feed-to-egg ratios were decreased in the hens in the HELPMC and HELPHC groups (p < 0.05).

3.2. Egg Quality

The effects of dietary COS supplementation on the egg quality of the laying hens are presented in Table 4. There were no significant differences in egg weight, egg shape index, yolk color, yolk weight ratio, eggshell strength or eggshell thickness among all the groups (p > 0.05). The hens in the HELP group showed significantly lower albumen height and Haugh unit values than those in the NC group (p < 0.05), whereas, compared with hens in the HELP group, albumen heights and Haugh units were increased in the hens in the HELPMC and HELPHC groups (p < 0.05).

3.3. Histopathology

The effects of COS supplementation on ovarian morphology in the laying hens are presented in Figure 1. The morphological structures of the ovaries in the hens in the NC group were normal, with orderly arrangements of granulosa cells. The ovaries in the hens in the HELP group showed decreased numbers of granulosa cells and loose and irregular arrangements of granulosa cells, whereas dietary COS supplementation, especially at the dosages of 400 or 800 mg/kg, inhibited ovary damage by alleviating these histological alterations.

3.4. Antioxidant Capacities of the Ovaries

As shown in Figure 2, there were no significant differences in ovarian GSH-Px activity among all the groups (p > 0.05). The hens in the HELP group showed significantly lower activities of ovarian T-AOC and higher levels of MDA compared with those in the NC group (p < 0.05), and there were no significant differences in ovarian SOD activities between the HELP group and the NC group (p > 0.05). When compared with hens in the HELP group, ovarian T-AOC and SOD activities were significantly increased in the hens in the HELPMC and HELPHC groups (p < 0.05), and MDA levels were significantly decreased in the hens in the HELPLC, HELPMC and HELPHC groups (p < 0.05).

3.5. The mRNA Expression of Inflammation-Related Genes in the Ovaries

As shown in Figure 3, mRNA expression levels of ovarian nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in the hens in the HELP group were significantly upregulated compared with those in the hens in the NC group (p < 0.05). Dietary supplementation with COS (400 or 800 mg/kg) obviously downregulated ovarian NF-κB mRNA expression (p < 0.05), and the COS administration (200, 400 or 800 mg/kg) significantly decreased the mRNA expression levels of TNF-α, IL-1β and IL-6 in the ovaries (p < 0.05).

3.6. The mRNA Expression of Apoptosis-Related Genes in the Ovaries

As shown in Figure 4, there were no significant differences in ovarian pro-apoptosis-related gene caspase 3 mRNA expression among all the groups (p > 0.05). The mRNA expressions of ovarian pro-apoptosis-related genes, including caspase 8, caspase 9 and B cell lymphoma-2 associated X protein (Bax), were significantly higher in the HELP group than in the NC group (p < 0.05), whereas dietary supplementation with COS (200, 400 or 800 mg/kg) obviously downregulated the mRNA expressions of caspase 8 and caspase 9 in the ovaries (p < 0.05); however, ovarian Bax mRNA expression was not affected by dietary COS supplementation (p > 0.05). Additionally, no difference was observed in ovarian anti-apoptosis-related gene B cell lymphoma-2 (Bcl-2) mRNA expression between the HELP group and the NC group (p > 0.05), while the hens administrated with COS (400 or 800 mg/kg) showed significantly higher Bcl-2 expression compared with the hens in the HELP group (p < 0.05).

4. Discussion

4.1. Production Performance

Laying hens with FLS often experience decreases in reproductive performance [2]. In this study, a HELP diet was used to induce FLS in laying hens, which is a typical approach taken to establish an FLS model [4]. We found that hens fed with a HELP diet showed lower laying rates and higher feed-to-egg ratios, which were consistent with the results of previous studies [4,7]. It has been reported that COS could improve production performance in laying hens under normal physiological conditions [18,19]. Our study is the first to demonstrate the beneficial effects of COS on laying rates and feed-to-egg ratios in laying hens with FLS. It is generally accepted that feed intake will decrease along with increase in dietary energy in laying hens [25]. Surprisingly, we found there was no significant difference in daily feed intake between the HELP group and the NC group. This result was inconsistent with those of previous studies [4,5], which indicated that HELP-diet-fed hens experienced decreased feed intake. However, Wu et al. reported that no difference was found in feed intake between the control group and an FLS group (induced by a high-fat diet) of laying hens [26]. Actually, according to the previous studies, dietary energy levels showed inconsistent effects on feed intake in laying hens. Zhang and Kim reported that the feed intake of hens fed a diet with 2800 kcal ME/kg was decreased when compared to those fed a diet with 2700 kcal ME/kg [27]. In other studies, changes in dietary energy levels did not affect feed intake in laying hens [28,29]. These discrepancies may be due to differences in genotype, age, diet composition or environment [30]. Additionally, dietary COS supplementation did not affect feed intake in laying hens with FLS, which was in agreement with the effect of COS supplementation in laying hens under normal physiological conditions [18,21].

4.2. Egg Quality

The literature on the effect of FLS on egg quality in laying hens is limited. Rozenboim et al. reported that egg weight was lower in a HELP group compared to the control [4]. In the present study, egg weight, egg shape index, yolk color, yolk weight ratio, eggshell strength and eggshell thickness were not affected by the HELP diet or COS supplementation. However, albumen heights and Haugh unit values were lower in the HELP group compared to the control, whereas dietary COS supplementation significantly increased albumen heights and Haugh units. To our knowledge, this is the first time the beneficial effect of COS on egg quality in laying hens with FLS has been reported. Similarly, previous studies on egg quality in laying hens under normal physiological conditions found that COS showed beneficial effects on egg-quality characteristics, including yolk color, eggshell strength, eggshell thickness, albumen height and Haugh unit [18,19,21,31,32]. Although the results were not entirely consistent, it can be concluded that COS is effective in improving egg quality in laying hens with or without FLS.

4.3. Ovarian Morphology

Metabolic disorders, including fatty liver disease, may cause abnormalities in the reproductive functions of humans and animals [33,34]. The ovary is the main organ in the reproductive system, and its dysfunction may be the major contributing factor with respect to decreased egg production and egg quality in laying hens with FLS. To explore the mechanisms underlying the effects of COS on production performance and egg quality in laying hens with FLS, ovarian morphology, ovarian antioxidant capacity and mRNA expression of genes related to ovarian inflammation and apoptosis were further examined. Walzem et al. reported that FLS induced follicular collapse and oviduct involution in laying hens [35]. Chen et al. found that hepatic fat accumulation is positively correlated with abnormal ovarian morphology in broiler breeder hens [6]. In our study, the histological examinations demonstrated that the numbers of granulosa cells were reduced and that the arrangements of the granulosa cells were damaged by the HELP diet in the laying hens, whereas dietary COS supplementation improved ovarian morphology.

4.4. Ovarian Antioxidant Capacity

Oxidative stress could induce ovarian dysfunction and result in reproductive failure [36]. Growing evidence has demonstrated that antioxidants may improve laying performance and ovarian function in hens [37,38]. In the present study, HELP-diet-fed hens showed lowered activities of antioxidant enzyme T-AOC and increased levels of the lipid peroxidation product MDA in the ovary, indicating that the ovaries of HELP-diet-fed hens suffered from increased oxidative stress and had decreased antioxidant capacities, which were consistent with the results of the study by Xing et al. [7]. Numerous studies in vitro and in vivo have demonstrated that COS possesses antioxidative properties [8]. Tao et al. reported that COS reduced hepatic oxidative stress in mice with fatty liver disease [14]. Yang et al. showed that COS alleviated hydrogen peroxide-stimulated oxidative damage in a human ovarian granulosa cell line [39]. Consistent with these findings, we found that dietary COS administration enhanced ovarian antioxidant capacity by increasing the activities of T-AOC and SOD and reducing levels of MDA.

4.5. Ovarian Inflammation

Fatty liver disease is closely associated with chronic systemic and local inflammation [40]. In women with polycystic ovary syndrome, a chronic ovarian pro-inflammatory state resulted in ovarian dysfunction [41]. In laying hens, the development of polycystic ovaries with cancer was related to chronic inflammation in the ovary [42]. There is only one study in the literature on the effect of FLS on ovarian inflammation in laying hens, reporting that inflammatory response was enhanced in the ovaries of hens with FLS [7]. Similarly, we found that HELP-diet-fed hens showed upregulated mRNA expression levels of NF-κB, TNF-α, IL-1β and IL-6 in the ovaries. As a transcription factor, NF-κB plays a critical role in various inflammatory-associated metabolic diseases, and its activation induces the production of proinflammatory cytokines TNF-α, IL-1β and IL-6 [43,44]. Due to its anti-inflammatory activity, COS has been used to prevent inflammatory-associated metabolic diseases [8,14]. In this study, dietary COS supplementation obviously downregulated mRNA expression of these inflammation-related genes, suggesting that COS inhibited ovarian inflammation in laying hens with FLS.

4.6. Ovarian Apoptosis

A previous study reported that hepatic fat accumulation is positively correlated with apoptosis in the ovaries in broiler breeder hens [6]. Additionally, it has been demonstrated that breeders with lower egg laying rates had higher ovarian-cell apoptosis rates [45]. Bcl-2 family proteins play important roles in the regulation of cellular apoptosis, among which Bcl-2 is the most representative anti-apoptotic protein, whereas Bax exhibits pro-apoptotic activity [46]. Upon receipt of an apoptotic signal, apoptotic initiators, including caspase 8 and caspase 9, are activated, and then a downstream apoptotic executor, such as caspase 3, is activated, ultimately resulting in apoptosis [47]. In the current study, we found that the mRNA expression levels of pro-apoptosis-related genes (caspase 8, caspase 9 and Bax) in the ovaries of HELP-diet-fed hens were significantly higher than those of NC-diet-fed hens. Increased ovarian apoptosis may be the main contributing factor with respect to the reduced numbers of granulosa cells in hens with FLS. Yang et al. showed that COS inhibited apoptosis in a human ovarian granulosa cell line under oxidative stress induced by hydrogen peroxide [39]. In agreement with these results, we found that dietary COS supplementation downregulated the mRNA expression of caspase 8 and caspase 9 and upregulated the mRNA expression of the anti-apoptosis-related gene Bcl-2 in the ovaries of HELP-diet-fed hens, suggesting that COS suppressed ovarian apoptosis in laying hens with FLS.

5. Conclusions

In conclusion, our results suggested that dietary COS supplementation, especially at the dosages of 400 or 800 mg/kg, could improve production performance and egg quality in laying hens with FLS, and these beneficial effects were linked to improved ovarian morphology, which was attributed to decreased oxidative stress, inflammation and apoptosis in the ovaries.

Author Contributions

Conceptualization, W.T. and J.W.; methodology, F.J., N.Z., E.D. and S.H.; software, Q.F. and G.W.; validation, F.J., Q.F. and M.C.; formal analysis, W.T. and N.Z.; investigation, W.T. and G.W.; resources, W.G. and E.D.; data curation, F.J. and Q.F.; writing—original draft preparation, W.T.; writing—review and editing, W.T. and J.W.; visualization, F.C.; supervision, W.T. and F.J.; project administration, W.T. and J.W; funding acquisition, W.T. and J.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the China Postdoctoral Science Foundation (2022M711096), Open Project of Key Laboratory of Molecular Animal Nutrition of Ministry of Education, Zhejiang University (KLMAN202001), Hubei Innovation Center of Agricultural Science and Technology (2016-620-000-001-028), and the National Natural Science Foundation of China (31702309).

Institutional Review Board Statement

The animal study protocol was approved by the Animal Care and Use Committee of Hubei Academy of Agricultural Sciences (HBAAS20210007).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shini, A.; Shini, S.; Bryden, W.L. Fatty liver haemorrhagic syndrome occurrence in laying hens: Impact of production system. Avian Pathol. 2019, 48, 25–34. [Google Scholar] [CrossRef] [PubMed]
  2. Trott, K.A.; Giannitti, F.; Rimoldi, G.; Hill, A.; Woods, L.; Barr, B.; Anderson, M.; Mete, A. Fatty liver hemorrhagic syndrome in the backyard chicken: A retrospective histopathologic case series. Vet. Pathol. 2014, 51, 787–795. [Google Scholar] [CrossRef] [PubMed]
  3. Squires, E.J.; Leeson, S. Aetiology of fatty liver syndrome in laying hens. Br. Vet. J. 1988, 144, 602–609. [Google Scholar] [CrossRef]
  4. Rozenboim, I.; Mahato, J.; Cohen, N.A.; Tirosh, O. Low protein and high-energy diet: A possible natural cause of fatty liver hemorrhagic syndrome in caged White Leghorn laying hens. Poult. Sci. 2016, 95, 612–621. [Google Scholar] [CrossRef]
  5. Jiang, S.; Cheng, H.W.; Cui, L.Y.; Zhou, Z.L.; Hou, J.F. Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. Poult. Sci. 2013, 92, 1443–1453. [Google Scholar] [CrossRef] [PubMed]
  6. Chen, S.E.; McMurtry, J.P.; Walzem, R.L. Overfeeding-induced ovarian dysfunction in broiler breeder hens is associated with lipotoxicity. Poult. Sci. 2006, 85, 70–81. [Google Scholar] [CrossRef] [PubMed]
  7. Xing, C.; Wang, Y.; Dai, X.; Yang, F.; Luo, J.; Liu, P.; Zhang, C.; Cao, H.; Hu, G. The protective effects of resveratrol on antioxidant function and the mRNA expression of inflammatory cytokines in the ovaries of hens with fatty liver hemorrhagic syndrome. Poult. Sci. 2020, 99, 1019–1027. [Google Scholar] [CrossRef] [PubMed]
  8. Muanprasat, C.; Chatsudthipong, V. Chitosan oligosaccharide: Biological activities and potential therapeutic applications. Pharmacol. Ther. 2017, 170, 80–97. [Google Scholar] [CrossRef] [PubMed]
  9. Naveed, M.; Phil, L.; Sohail, M.; Hasnat, M.; Baig, M.; Ihsan, A.U.; Shumzaid, M.; Kakar, M.U.; Mehmood Khan, T.; Akabar, M.D.; et al. Chitosan oligosaccharide (COS): An overview. Int. J. Biol. Macromol. 2019, 129, 827–843. [Google Scholar] [CrossRef]
  10. Tao, W.; Wang, G.; Wei, J. The role of chitosan oligosaccharide in metabolic syndrome: A review of possible mechanisms. Mar. Drugs 2021, 19, 501. [Google Scholar] [CrossRef] [PubMed]
  11. Deng, X.; Ye, Z.; Cao, H.; Bai, Y.; Che, Q.; Guo, J.; Su, Z. Chitosan oligosaccharide ameliorated obesity by reducing endoplasmic reticulum stress in diet-induced obese rats. Food Funct. 2020, 11, 6285–6296. [Google Scholar] [CrossRef]
  12. He, N.; Wang, S.; Lv, Z.; Zhao, W.; Li, S. Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in high-fat diet (HFD)-fed mice. Food Funct. 2020, 11, 9947–9959. [Google Scholar] [CrossRef] [PubMed]
  13. Zheng, J.; Yuan, X.; Cheng, G.; Jiao, S.; Feng, C.; Zhao, X.; Yin, H.; Du, Y.; Liu, H. Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice. Carbohydr. Polym. 2018, 190, 77–86. [Google Scholar] [CrossRef]
  14. Tao, W.; Sun, W.; Liu, L.; Wang, G.; Xiao, Z.; Pei, X.; Wang, M. Chitosan oligosaccharide attenuates nonalcoholic fatty liver disease induced by high fat diet through reducing lipid accumulation, inflammation and oxidative stress in C57BL/6 mice. Mar. Drugs 2019, 17, 645. [Google Scholar] [CrossRef] [PubMed]
  15. Qian, M.; Lyu, Q.; Liu, Y.; Hu, H.; Wang, S.; Pan, C.; Duan, X.; Gao, Y.; Qi, L.W.; Liu, W.; et al. Chitosan oligosaccharide ameliorates nonalcoholic fatty liver disease (NAFLD) in diet-induced obese mice. Mar. Drugs 2019, 17, 391. [Google Scholar] [CrossRef] [PubMed]
  16. Wan, J.; Yang, K.; Xu, Q.; Chen, D.; Yu, B.; Luo, Y.; He, J. Dietary chitosan oligosaccharide supplementation improves foetal survival and reproductive performance in multiparous sows. RSC Adv. 2016, 6, 70715–70722. [Google Scholar] [CrossRef]
  17. Cheng, L.K.; Wang, L.X.; Xu, Q.S.; Huang, L.J.; Zhou, D.S.; Li, Z.; Li, S.G.; Du, Y.G.; Yin, H. Chitooligosaccharide supplementation improves the reproductive performance and milk composition of sows. Livest. Sci. 2015, 174, 74–81. [Google Scholar] [CrossRef]
  18. Xu, Q.; Azzam, M.M.M.; Zou, X.; Dong, X. Effects of chitooligosaccharide supplementation on laying performance, egg quality, blood biochemistry, antioxidant capacity and immunity of laying hens during the late laying period. Ital. J. Anim. Sci. 2020, 19, 1181–1188. [Google Scholar] [CrossRef]
  19. Meng, Q.W.; Yan, L.; Ao, X.; Jang, H.D.; Cho, J.H.; Kim, I.H. Effects of chito-oligosaccharide supplementation on egg production, nutrient digestibility, egg quality and blood profiles in laying hens. Asian-Australas. J. Anim. Sci. 2010, 23, 1476–1481. [Google Scholar] [CrossRef]
  20. Xu, Q.; Qu, C.; Wan, J.; Cheng, G.; Yang, W.; Gong, C.; He, J.; Du, Y. Effect of dietary chitosan oligosaccharide supplementation on the pig ovary transcriptome. RSC Adv. 2018, 8, 13266–13273. [Google Scholar] [CrossRef] [Green Version]
  21. Gu, Y.F.; Chen, Y.P.; Jin, R.; Wang, C.; Wen, C.; Zhou, Y.M. Dietary chitooligosaccharide supplementation alleviates intestinal barrier damage, and oxidative and immunological stress in lipopolysaccharide-challenged laying hens. Poult. Sci. 2022, 101, 101701. [Google Scholar] [CrossRef] [PubMed]
  22. Lan, R.; Wei, L.; Chang, Q.; Wu, S.; Zhao, Z. Effects of dietary chitosan oligosaccharides on oxidative stress and inflammation response in liver and spleen of yellow-feather broilers exposed to high ambient temperature. Ital. J. Anim. Sci. 2020, 19, 1508–1517. [Google Scholar] [CrossRef]
  23. Lan, R.; Li, Y.; Chang, Q.; Zhao, Z. Dietary chitosan oligosaccharides alleviate heat stress–induced intestinal oxidative stress and inflammatory response in yellow-feather broilers. Poult. Sci. 2020, 99, 6745–6752. [Google Scholar] [CrossRef] [PubMed]
  24. National Research Council. Nutrient Requirements of Poultry, 9th ed.; National Academy Press: Washington, DC, USA, 1994. [Google Scholar]
  25. Harms, R.H.; Russell, G.B.; Sloan, D.R. Performance of four strains of commercial layers with major changes in dietary energy. J. Appl. Poult. Res. 2000, 9, 535–541. [Google Scholar] [CrossRef]
  26. Wu, X.L.; Zou, X.Y.; Zhang, M.; Hu, H.Q.; Wei, X.L.; Jin, M.L.; Cheng, H.W.; Jiang, S. Osteocalcin prevents insulin resistance, hepatic inflammation, and activates autophagy associated with high-fat diet-induced fatty liver hemorrhagic syndrome in aged laying hens. Poult. Sci. 2021, 100, 73–83. [Google Scholar] [CrossRef] [PubMed]
  27. Zhang, Z.F.; Kim, I.H. Effects of probiotic supplementation in different energy and nutrient density diets on performance, egg quality, excreta microflora, excreta noxious gas emission, and serum cholesterol concentrations in laying hens. J. Anim. Sci. 2013, 91, 4781–4787. [Google Scholar] [CrossRef]
  28. Jalal, M.A.; Scheideler, S.E.; Pierson, E.M. Strain response of laying hens to varying dietary energy levels with and without Avizyme supplementation. J. Appl. Poult. Res. 2007, 16, 289–295. [Google Scholar] [CrossRef]
  29. Mikulski, D.; Jankowski, J.; Mikulska, M.; Demey, V. Effects of dietary probiotic (Pediococcus acidilactici) supplementation on productive performance, egg quality, and body composition in laying hens fed diets varying in energy density. Poult. Sci. 2020, 99, 2275–2285. [Google Scholar] [CrossRef] [PubMed]
  30. Classen, H.L. Diet energy and feed intake in chickens. Anim. Feed Sci. Technol. 2017, 233, 13–21. [Google Scholar] [CrossRef]
  31. Yan, L.; Lee, J.H.; Meng, Q.W.; Ao, X.; Kim, I.H. Evaluation of dietary supplementation of delta-aminolevulinic acid and chito-oligosaccharide on production performance, egg quality and hematological characteristics in laying hens. Asian-Australas. J. Anim. Sci. 2010, 23, 1028–1033. [Google Scholar] [CrossRef]
  32. Jiao, Y.; Jha, R.; Zhang, W.L.; Kim, I.H. Effects of chitooligosaccharide supplementation on egg production, egg quality and blood profiles in laying hens. Indian, J. Anim. Res. 2019, 53, 1199–1204. [Google Scholar] [CrossRef]
  33. Mellouk, N.; Ramé, C.; Barbe, A.; Grandhaye, J.; Froment, P.; Dupont, J. Chicken is a useful model to investigate the role of adipokines in metabolic and reproductive diseases. Int. J. Endocrinol. 2018, 2018, 4579734. [Google Scholar] [CrossRef]
  34. Won, Y.B.; Seo, S.K.; Yun, B.H.; Cho, S.; Choi, Y.S.; Lee, B.S. Non-alcoholic fatty liver disease in polycystic ovary syndrome women. Sci. Rep. 2021, 11, 7085. [Google Scholar] [CrossRef]
  35. Walzem, R.L.; Simon, C.; Morishita, T.; Lowenstine, L.; Hansen, R.J. Fatty liver hemorrhagic syndrome in hens overfed a purified diet. Selected enzyme activities and liver histology in relation to liver hemorrhage and reproductive performance. Poult. Sci. 1993, 72, 1479–1491. [Google Scholar] [CrossRef]
  36. Devine, P.J.; Perreault, S.D.; Luderer, U. Roles of reactive oxygen species and antioxidants in ovarian toxicity. Biol. Reprod. 2012, 86, 27. [Google Scholar] [CrossRef]
  37. Liu, X.; Lin, X.; Mi, Y.; Li, J.; Zhang, C. Grape seed proanthocyanidin extract prevents ovarian aging by inhibiting oxidative stress in the hens. Oxidative Med. Cell. Longev. 2018, 2018, 9390810. [Google Scholar] [CrossRef]
  38. Wang, J.; Jia, R.; Gong, H.; Celi, P.; Zhuo, Y.; Ding, X.; Bai, S.; Zeng, Q.; Yin, H.; Xu, S.; et al. The effect of oxidative stress on the chicken ovary: Involvement of microbiota and melatonin interventions. Antioxidants 2021, 10, 1422. [Google Scholar] [CrossRef]
  39. Yang, Z.; Hong, W.; Zheng, K.; Feng, J.; Hu, C.; Tan, J.; Zhong, Z.; Zheng, Y. Chitosan oligosaccharides alleviate H2O2-stimulated granulosa cell damage via HIF-1α signaling pathway. Oxidative Med. Cell. Longev. 2022, 2022, 4247042. [Google Scholar] [CrossRef]
  40. Luci, C.; Bourinet, M.; Leclère, P.S.; Anty, R.; Gual, P. Chronic inflammation in non-alcoholic steatohepatitis: Molecular mechanisms and therapeutic strategies. Front. Endocrinol. 2020, 11, 597648. [Google Scholar] [CrossRef]
  41. Velez, L.M.; Seldin, M.; Motta, A.B. Inflammation and reproductive function in women with polycystic ovary syndrome. Biol. Reprod. 2021, 104, 1205–1217. [Google Scholar] [CrossRef]
  42. Lee, H.J.; Bahr, J.M.; Bitterman, P.; Basu, S.; Sharma, S.; Abramowicz, J.S.; Barua, A. Polycystic ovarian condition may be a risk factor for ovarian tumor development in the laying hen model of spontaneous ovarian cancer. J. Immunol. Res. 2018, 2018, 2590910. [Google Scholar] [CrossRef] [PubMed]
  43. Baker, R.G.; Hayden, M.S.; Ghosh, S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011, 13, 11–22. [Google Scholar] [CrossRef] [PubMed]
  44. Yu, H.; Lin, L.; Zhang, Z.; Zhang, H.; Hu, H. Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduct. Target. Ther. 2020, 5, 209. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, J.; Zhang, H.; Bai, S.; Zeng, Q.; Su, Z.; Zhuo, Y.; Mao, X.; Yin, H.; Feng, B.; Liu, J.; et al. Dietary tributyrin improves reproductive performance, antioxidant capacity, and ovary function of broiler breeders. Poult. Sci. 2021, 100, 101429. [Google Scholar] [CrossRef]
  46. Birkinshaw, R.W.; Czabotar, P.E. The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation. Semin. Cell Dev. Biol. 2017, 72, 152–162. [Google Scholar] [CrossRef]
  47. Boice, A.; Bouchier-Hayes, L. Targeting apoptotic caspases in cancer. Biochim. Biophys. Acta Mol. Cell Res. 2020, 1867, 118688. [Google Scholar] [CrossRef]
Figure 1. Effects of chitosan oligosaccharide on ovarian morphology in the laying hens. Representative images of the ovaries stained with hematoxylin and eosin. Abbreviations: HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; NC, normal control.
Figure 1. Effects of chitosan oligosaccharide on ovarian morphology in the laying hens. Representative images of the ovaries stained with hematoxylin and eosin. Abbreviations: HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; NC, normal control.
Animals 12 02465 g001
Figure 2. Effects of chitosan oligosaccharide on ovarian antioxidant capacity in the laying hens. (A) T-AOC, (B) GSH-Px, (C) SOD activities and (D) MDA levels in the ovaries. Each mean represents one layer/replicate, six replicates/treatment. Means lacking a common superscript are significantly different (p < 0.05). Abbreviations: GSH-Px, glutathione peroxidase; HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; MDA, malondialdehyde; NC, normal control; SOD, superoxide dismutase; T-AOC, total antioxidant capacity.
Figure 2. Effects of chitosan oligosaccharide on ovarian antioxidant capacity in the laying hens. (A) T-AOC, (B) GSH-Px, (C) SOD activities and (D) MDA levels in the ovaries. Each mean represents one layer/replicate, six replicates/treatment. Means lacking a common superscript are significantly different (p < 0.05). Abbreviations: GSH-Px, glutathione peroxidase; HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; MDA, malondialdehyde; NC, normal control; SOD, superoxide dismutase; T-AOC, total antioxidant capacity.
Animals 12 02465 g002
Figure 3. Effects of chitosan oligosaccharide on ovarian inflammation in the laying hens. Relative mRNA expression of (A) NF-κB, (B) TNF-α, (C) IL-1β and (D) IL-6 in the ovaries. Each mean represents one layer/replicate, six replicates/treatment. Means lacking a common superscript are significantly different (p < 0.05). Abbreviations: HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; IL-1β, interleukin-1β; IL-6, interleukin-6; NC, normal control; NF-κB, nuclear factor kappa B; TNF-α, tumor necrosis factor-α.
Figure 3. Effects of chitosan oligosaccharide on ovarian inflammation in the laying hens. Relative mRNA expression of (A) NF-κB, (B) TNF-α, (C) IL-1β and (D) IL-6 in the ovaries. Each mean represents one layer/replicate, six replicates/treatment. Means lacking a common superscript are significantly different (p < 0.05). Abbreviations: HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; IL-1β, interleukin-1β; IL-6, interleukin-6; NC, normal control; NF-κB, nuclear factor kappa B; TNF-α, tumor necrosis factor-α.
Animals 12 02465 g003
Figure 4. Effects of chitosan oligosaccharide on ovarian apoptosis-related gene expression in the laying hens. Relative mRNA expression of (A) caspase 3, (B) caspase 8, (C) caspase 9, (D) Bax and (E) Bcl-2 in the ovaries. Each mean represents one layer/replicate, six replicates/treatment. Means lacking a common superscript are significantly different (p < 0.05). Abbreviations: Bax, B cell lymphoma-2 associated X protein; Bcl-2, B cell lymphoma-2; HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; NC, normal control.
Figure 4. Effects of chitosan oligosaccharide on ovarian apoptosis-related gene expression in the laying hens. Relative mRNA expression of (A) caspase 3, (B) caspase 8, (C) caspase 9, (D) Bax and (E) Bcl-2 in the ovaries. Each mean represents one layer/replicate, six replicates/treatment. Means lacking a common superscript are significantly different (p < 0.05). Abbreviations: Bax, B cell lymphoma-2 associated X protein; Bcl-2, B cell lymphoma-2; HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; NC, normal control.
Animals 12 02465 g004
Table 1. Composition and nutrient levels of diets (air-dried basis).
Table 1. Composition and nutrient levels of diets (air-dried basis).
Items (%, Unless Otherwise Indicated)Basal DietHigh-Energy Low-Protein Diet
Ingredients
Corn63.0066.00
Soybean meal24.0017.20
Limestone8.008.00
Soybean oil0.003.80
Premix 15.005.00
Total100.00100.00
Nutrient levels 2
Metabolic energy (kcal/kg)2602.202854.34
Crude protein15.6512.88
Lysine0.790.62
Methionine 0.350.32
Calcium3.413.39
Total phosphorus0.430.40
1 Provided per kilogram of diet: Cu, 90 mg; Fe, 560 mg; Zn, 950 mg; Mn, 1080 mg; Se, 4.3 mg; I, 6 mg; vitamin A, 132,000 IU; vitamin D3, 45,000 IU; vitamin E, 280 mg; vitamin K3, 35 mg; vitamin B1, 18 mg; vitamin B2, 70 mg; vitamin B6, 36 mg; pantothenic acid, 110 mg; niacinamide, 285 mg; folic acid, 16 mg; biotin, 1.5 mg. 2 Calculated according to the Feed Database in China (2020).
Table 2. Primer sequences used in this study.
Table 2. Primer sequences used in this study.
GenePrimer Sequences (5′–3′)Size (bp)
GAPDHF: TGCTGCCCAGAACATCATCC
R: ACGGCAGGTCAGGTCAACAA
142
NF-κBF: TCAACGCAGGACCTAAAGACAT
R: GCAGATAGCCAAGTTCAGGATG
162
TNF-αF: GCCCTTCCTGTAACCAGATG
R: ACACGACAGCCAAGTCAACG
71
IL-1βF: ACTGGGCATCAAGGGCTA
R: GGTAGAAGATGAAGCGGGTC
131
IL-6F: AGGACGAGATGTGCAAGAAGT
R: TTGGGCAGGTTGAGGTTGTT
79
caspase 3F: AAAGATGGACCACGCTCAGG
R: TGAACGAGATGACAGTCCGG
204
caspase 8F: AGTGAACAACTATCGGTGCAT
R: CTTCCTGCCCATCAACACCA
107
caspase 9F: TATGGTGGAGGACATGCAGA
R: AATATTGGGAAGGCCTGCTT
99
BaxF: GTACGTCAATGTGGTCACCC
R: TGGGATAATGCTGGGGTTGA
210
Bcl-2F: ACCATGAATGAAACCGTGCC
R: TTGTCGTAGCCTCTTCTCCC
181
Abbreviations: Bax, B cell lymphoma-2 associated X protein; Bcl-2, B cell lymphoma-2; bp, base pair; F, forward; IL-1β, interleukin-1β; IL-6, interleukin-6; NF-κB, nuclear factor kappa B; R, reverse; TNF-α, tumor necrosis factor-α.
Table 3. Effects of chitosan oligosaccharide on production performance in the laying hens.
Table 3. Effects of chitosan oligosaccharide on production performance in the laying hens.
Items 1NCHELPHELPLCHELPMCHELPHCSEMp-Values
1st to 4th week
Laying rate (%)94.79 a92.07 b94.21 ab95.66 a95.54 a0.4300.042
Daily feed intake (g/hen/d)111.45111.49111.53111.68111.560.0410.461
Feed-to-egg ratio2.082.152.122.062.070.0110.054
5th to 8th week
Laying rate (%)92.88 a86.34 b90.80 a92.77 a92.48 a0.620<0.001
Daily feed intake (g/hen/d)111.07111.05111.14111.16111.160.0230.416
Feed-to-egg ratio2.10 b2.27 a2.16 b2.10 b2.11 b0.0170.002
9th to 12th week
Laying rate (%)90.97 a83.00 b86.34 ab88.08 a89.06 a0.7950.011
Daily feed intake (g/hen/d)107.63108.27107.24106.99106.980.2330.379
Feed-to-egg ratio2.11 b2.37 a2.25 ab2.20 b2.15 b0.0270.016
1st to 12th week
Laying rate (%)92.88 a87.14 b90.45 a92.17 a92.36 a0.5680.002
Daily feed intake (g/hen/d)110.05110.27109.97109.94109.900.0800.650
Feed-to-egg ratio2.10 b2.26 a2.18 ab2.12 b2.11 b0.0180.012
Abbreviations: HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energy low-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; NC, normal control. a,b Means within a row lacking a common superscript differ significantly (p < 0.05). 1 Each mean represents 12 layers/replicate, 6 replicates/treatment.
Table 4. Effects of chitosan oligosaccharide on egg quality in the laying hens.
Table 4. Effects of chitosan oligosaccharide on egg quality in the laying hens.
Items 1NCHELPHELPLCHELPMCHELPHCSEMp-Values
Egg weight (g)55.7455.8455.6255.3155.720.2110.955
Egg shape index1.331.331.331.331.340.0030.844
Yolk color6.216.636.336.486.250.0750.376
Yolk weight ratio (%)26.6626.9127.4726.9226.990.1340.447
Eggshell strength (N)44.9848.3247.7447.5848.420.5570.288
Eggshell thickness (μm)363.45361.85360.83363.33363.471.4650.975
Albumen height (mm)6.89 ab6.44 c6.65 bc6.88 ab7.15 a0.0700.008
Haugh unit84.02 ab80.79 c82.45 bc84.05 ab85.58 a0.4450.003
Abbreviations: HELP, high-energy low-protein; HELPLC, HELPMC and HELPHC, high-energylow-protein diet supplemented with 200, 400 and 800 mg/kg chitosan oligosaccharide, respectively; NC, normal control. a–c Means within a row lacking a common superscript differ significantly (p < 0.05). 1 Each mean represents eight eggs/replicate, six replicates/treatment.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tao, W.; Jin, F.; Fan, Q.; Zhao, N.; Wang, G.; Du, E.; Chen, F.; Guo, W.; Huang, S.; Chen, M.; et al. Effects of Chitosan Oligosaccharide on Production Performance, Egg Quality and Ovarian Function in Laying Hens with Fatty Liver Syndrome. Animals 2022, 12, 2465. https://doi.org/10.3390/ani12182465

AMA Style

Tao W, Jin F, Fan Q, Zhao N, Wang G, Du E, Chen F, Guo W, Huang S, Chen M, et al. Effects of Chitosan Oligosaccharide on Production Performance, Egg Quality and Ovarian Function in Laying Hens with Fatty Liver Syndrome. Animals. 2022; 12(18):2465. https://doi.org/10.3390/ani12182465

Chicago/Turabian Style

Tao, Wenjing, Feng Jin, Qiwen Fan, Na Zhao, Geng Wang, Encun Du, Fang Chen, Wanzheng Guo, Shaowen Huang, Mingxin Chen, and et al. 2022. "Effects of Chitosan Oligosaccharide on Production Performance, Egg Quality and Ovarian Function in Laying Hens with Fatty Liver Syndrome" Animals 12, no. 18: 2465. https://doi.org/10.3390/ani12182465

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop